scispace - formally typeset
E

Etienne Rouleau

Researcher at Institut Gustave Roussy

Publications -  197
Citations -  6654

Etienne Rouleau is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 36, co-authored 145 publications receiving 4996 citations. Previous affiliations of Etienne Rouleau include Huntsman Cancer Institute & Université Paris-Saclay.

Papers
More filters
Journal ArticleDOI

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto, +98 more
- 01 Dec 2011 - 
TL;DR: A germline missense substitution in MITF (Mi-E318K) is identified that occurred at a significantly higher frequency in genetically enriched patients affected with melanoma, RCC or both cancers, when compared with controls and provides insights into the link between SUMOylation, transcription and cancer.
Journal ArticleDOI

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fergus J. Couch, +261 more
- 27 Mar 2013 - 
TL;DR: It is estimated that the breast cancer lifetime risks for the5% of BRCA1 carriers at lowest risk are 28%–50% compared to 81%–100% for the 5% at highest risk, and the ovarian cancer lifetime risk is 63% or higher, based on the known cancer risk-modifying loci.
Journal ArticleDOI

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Timothy R. Rebbeck, +261 more
- 07 Apr 2015 - 
TL;DR: In this paper, the relationship between specific mutations in BRCA1 and cancer risk has been investigated and limited information about the relationship has been available about specific mutations for specific mutations.
Journal ArticleDOI

Down-regulation of BRCA1 Expression by miR-146a and miR-146b-5p in Triple Negative Sporadic Breast Cancers

TL;DR: This work provides further evidence for the involvement of miRNAs in sporadic breast cancer through down‐regulation of BRCA1 through binding to the same site in the 3′UTR of BrcA1 and down‐regulate its expression as demonstrated using reporter assays.